Strs Ohio Boosts Holdings in The Clorox Company $CLX

Strs Ohio raised its holdings in The Clorox Company (NYSE:CLX) by 52.7% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,935 shares of the company’s stock after buying an additional 5,498 shares during the period. Strs Ohio’s holdings in Clorox were worth $1,913,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. American National Bank & Trust boosted its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the period. Hantz Financial Services Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at about $31,000. Ransom Advisory Ltd purchased a new position in shares of Clorox in the 1st quarter valued at about $35,000. GW&K Investment Management LLC boosted its stake in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after buying an additional 208 shares during the period. Finally, Bogart Wealth LLC boosted its stake in shares of Clorox by 289.5% in the 2nd quarter. Bogart Wealth LLC now owns 370 shares of the company’s stock valued at $44,000 after buying an additional 275 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is currently owned by company insiders.

Clorox Price Performance

Shares of CLX opened at $110.41 on Wednesday. The Clorox Company has a 1-year low of $107.71 and a 1-year high of $171.37. The stock has a market cap of $13.44 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a fifty day moving average price of $120.13 and a 200 day moving average price of $125.40.

Clorox (NYSE:CLX) last posted its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the previous year, the business earned $1.86 EPS. The business’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.5%. Clorox’s payout ratio is currently 76.07%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. The Goldman Sachs Group decreased their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. Bank of America decreased their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Barclays decreased their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. Wells Fargo & Company decreased their price target on Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a report on Tuesday. Finally, Citigroup decreased their target price on Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a research note on Tuesday. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. According to MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $127.60.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.